Tag: Peter Francis
4DMT choroideremia therapy secures FDA orphan drug designation
4D Molecular Therapeutics (4DMT), a California-based gene therapy company, has secured orphan drug designation for 4D-110 from the US Food and Drug Administration (FDA) for ... Read More